These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34629181)

  • 1. Parkinsonism in viral, paraneoplastic, and autoimmune diseases.
    Xing F; Marsili L; Truong DD
    J Neurol Sci; 2022 Feb; 433():120014. PubMed ID: 34629181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The etiopathogenetic and pathophysiological spectrum of parkinsonism.
    Bologna M; Truong D; Jankovic J
    J Neurol Sci; 2022 Feb; 433():120012. PubMed ID: 34642022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism and tremor syndromes.
    Bellows S; Jankovic J
    J Neurol Sci; 2022 Feb; 433():120018. PubMed ID: 34686357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism and ataxia.
    Franco G; Lazzeri G; Di Fonzo A
    J Neurol Sci; 2022 Feb; 433():120020. PubMed ID: 34711421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism and dystonia: Clinical spectrum and diagnostic clues.
    Morales-Briceno H; Fung VSC; Bhatia KP; Balint B
    J Neurol Sci; 2022 Feb; 433():120016. PubMed ID: 34642024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism and cerebrovascular disease.
    Narasimhan M; Schwartz R; Halliday G
    J Neurol Sci; 2022 Feb; 433():120011. PubMed ID: 34686356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonism and dementia.
    Koros C; Stefanis L; Scarmeas N
    J Neurol Sci; 2022 Feb; 433():120015. PubMed ID: 34642023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viruses, parkinsonism and Parkinson's disease: the past, present and future.
    Leta V; Urso D; Batzu L; Lau YH; Mathew D; Boura I; Raeder V; Falup-Pecurariu C; van Wamelen D; Ray Chaudhuri K
    J Neural Transm (Vienna); 2022 Sep; 129(9):1119-1132. PubMed ID: 36036863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinsonism and cerebrospinal fluid disorders.
    Youn J; Todisco M; Zappia M; Pacchetti C; Fasano A
    J Neurol Sci; 2022 Feb; 433():120019. PubMed ID: 34674853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
    Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional neurological disorder and somatic symptom disorder in Parkinson's disease.
    Onofrj M; Russo M; Carrarini C; Delli Pizzi S; Thomas A; Bonanni L; Espay AJ; Sensi SL
    J Neurol Sci; 2022 Feb; 433():120017. PubMed ID: 34629180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonism in autoimmune diseases.
    Barba C; Alexopoulos H
    Int Rev Neurobiol; 2019; 149():419-452. PubMed ID: 31779823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Part of the Covid19 puzzle: Acute parkinsonism.
    Akilli NB; Yosunkaya A
    Am J Emerg Med; 2021 Sep; 47():333.e1-333.e3. PubMed ID: 33712341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and Parkinsonism: A Critical Appraisal.
    Cavallieri F; Fioravanti V; Bove F; Del Prete E; Meoni S; Grisanti S; Zedde M; Pascarella R; Moro E; Valzania F
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.
    Orta Daniel SJ; Ulises RO
    Parkinsonism Relat Disord; 2008; 14(4):367-9. PubMed ID: 18455950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease.
    Zhang J
    Front Neurol; 2022; 13():968193. PubMed ID: 36570463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus with secondary thrombotic thrombocytopenic purpura and acute parkinsonism: A case report.
    Deepak P; Memon RS; Tariq F; Ahmed H; Bhatti S
    J Pak Med Assoc; 2021 Dec; 71(12):2812-2816. PubMed ID: 35150545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinsonism hyperpyraexia syndrome in Parkinson's disease patients undergoing deep brain stimulation: An indirect consequence of COVID-19 lockdowns.
    Phokaewvarangkul O; Virameteekul S; Bhidayasiri R
    Parkinsonism Relat Disord; 2021 Jun; 87():39-40. PubMed ID: 33940565
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines.
    Dulski J; Sławek J
    Neurol Neurochir Pol; 2023; 57(1):53-62. PubMed ID: 36799523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Post-COVID-19 Parkinsonism in the Future?
    Boika AV
    Mov Disord; 2020 Jul; 35(7):1094. PubMed ID: 32395872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.